Effect of etimizole structural analogues on protein kinase CK2, protein phosphorylation and transcription of chromatin in rat brain cortex and hippocampus
Protein kinase CK2 is an important enzyme in the nervous system. The nuclear forms of CK2 regulate chromatin structure and gene expression, the key processes for long-term memory formation. Memory modulators, the Structural Analogues of Etimizole (SAE), were able to increase or decrease the activity of chromatin-associated CK in the cortex and hippocampus of rat brain in vitro. In vivo memory enhancers from SAE-group (3 mg/kg) stimulated CK2 activity and the transcriptional ability of chromatin in the cortex and hippocampus, starting from 30 min with a peak for 60 min and a duration up to 180 min. At these periods the memory inhibitor from the SAE-group reduced CK2 activity and chromatin transcription. It is assumed that the modulating effect of SAE on CK2 activity and transcription underlies the effects of these compounds on long-term memory.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
---|---|
Enthalten in: |
Biomeditsinskaia khimiia - 66(2020), 2 vom: 01. Feb., Seite 130-137 |
Sprache: |
Russisch |
---|
Weiterer Titel: |
Vliianie strukturnykh analogov étimizola na proteinkinazu SK2, fosforilirovanie belkov i transkriptsiiu khromatina neĭronov kory i gippokampa mozga krys |
---|
Beteiligte Personen: |
Reikhardt, B A [VerfasserIn] |
---|
Links: |
---|
Themen: |
Brain |
---|
Anmerkungen: |
Date Completed 08.09.2020 Date Revised 08.09.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.18097/PBMC20206602130 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM310035163 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM310035163 | ||
003 | DE-627 | ||
005 | 20231225135223.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||rus c | ||
024 | 7 | |a 10.18097/PBMC20206602130 |2 doi | |
028 | 5 | 2 | |a pubmed24n1033.xml |
035 | |a (DE-627)NLM310035163 | ||
035 | |a (NLM)32420893 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a rus | ||
100 | 1 | |a Reikhardt, B A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of etimizole structural analogues on protein kinase CK2, protein phosphorylation and transcription of chromatin in rat brain cortex and hippocampus |
246 | 3 | 3 | |a Vliianie strukturnykh analogov étimizola na proteinkinazu SK2, fosforilirovanie belkov i transkriptsiiu khromatina neĭronov kory i gippokampa mozga krys |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.09.2020 | ||
500 | |a Date Revised 08.09.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Protein kinase CK2 is an important enzyme in the nervous system. The nuclear forms of CK2 regulate chromatin structure and gene expression, the key processes for long-term memory formation. Memory modulators, the Structural Analogues of Etimizole (SAE), were able to increase or decrease the activity of chromatin-associated CK in the cortex and hippocampus of rat brain in vitro. In vivo memory enhancers from SAE-group (3 mg/kg) stimulated CK2 activity and the transcriptional ability of chromatin in the cortex and hippocampus, starting from 30 min with a peak for 60 min and a duration up to 180 min. At these periods the memory inhibitor from the SAE-group reduced CK2 activity and chromatin transcription. It is assumed that the modulating effect of SAE on CK2 activity and transcription underlies the effects of these compounds on long-term memory | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a brain | |
650 | 4 | |a chromatin | |
650 | 4 | |a long-term memory | |
650 | 4 | |a protein kinase CK2 | |
650 | 4 | |a protein phosphorylation | |
650 | 4 | |a transcription | |
650 | 7 | |a Chromatin |2 NLM | |
650 | 7 | |a Casein Kinase II |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
650 | 7 | |a Etimizol |2 NLM | |
650 | 7 | |a NG2MF3646P |2 NLM | |
700 | 1 | |a Shabanov, P D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biomeditsinskaia khimiia |d 2003 |g 66(2020), 2 vom: 01. Feb., Seite 130-137 |w (DE-627)NLM142863602 |x 2310-6972 |7 nnns |
773 | 1 | 8 | |g volume:66 |g year:2020 |g number:2 |g day:01 |g month:02 |g pages:130-137 |
856 | 4 | 0 | |u http://dx.doi.org/10.18097/PBMC20206602130 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 66 |j 2020 |e 2 |b 01 |c 02 |h 130-137 |